GILEAD SCIENCES INC
GILDNASDAQ$149.88▼ $2.29 (−1.53%)
LiveTrack GILD
Get earnings, price moves & breaking news on Telegram
24h▼ 1.5%
7d▼ 1.8%
14d▲ 2.4%
30d▲ 2.9%
ytd▲ 22.1%
1y▲ 33.1%
🏦Market Cap
$185.85B
Mid Cap
📈Revenue Growth (YoY)
+2.4%
Slowing
📊Gross Margin
79.6%
High
💵FCF Margin
43.3%
Strong
⚖️P/S Ratio
6.1x
Fair
Otter Score
72
Fair
GILEAD SCIENCES INC
GILDAnalyst Ratings
Price
$149.88
Total
58
Raised
11
Lowered
6
Avg PT
$150.00
H / L
$175 / $123
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HSBC | Reiterated | Buy | 2026-09-10 | $175.00 | +16.80% |
RBC Capital | Reiterated | Sector Perform | 2026-08-05 | $123.00 | −17.90% |
Needham | Reiterated | Buy | 2026-08-05 | $170.00 | +13.40% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-05 | $155.00 | +3.40% |
Barclays | Reiterated | Equal Weight | 2026-07-29 | $145.00 | −3.30% |
Morgan Stanley | Reiterated | Overweight | 2026-07-27 | $165.00 | +10.10% |
Leerink Partners | Downgraded | Outperform → Market Perform | 2026-07-21 | $127.00 | −15.30% |
Truist Securities | Reiterated | Buy | 2026-07-07 | — | — |
Maxim Group | Upgraded | Hold → Buy | 2026-05-20 | $165.00 | +10.10% |
Citigroup | Reiterated | Buy | 2026-04-13 | — | — |
Scotiabank | Reiterated | Sector Outperform | 2026-02-11 | $177.00 | +18.10% |
Wells Fargo | Reiterated | Overweight | 2026-02-11 | $165.00 | +10.10% |
UBS | Reiterated | Buy | 2026-01-26 | $175.00 | +16.80% |
JP Morgan | Reiterated | Overweight | 2025-10-31 | — | — |
TD Cowen | Reiterated | Buy | 2025-10-23 | — | — |
BMO Capital | Reiterated | Outperform | 2025-08-08 | $160.00 | +6.80% |
Mizuho | Reiterated | Outperform | 2025-05-05 | — | — |
Oppenheimer | Reiterated | Outperform | 2025-04-25 | $165.00 | +10.10% |
B of A Securities | Reiterated | Buy | 2025-03-05 | — | — |
Deutsche Bank | Upgraded | Hold → Buy | 2025-02-18 | $135.00 | −9.90% |
Goldman Sachs | Reiterated | Neutral | 2025-02-12 | $71.00 | −52.60% |
Piper Sandler | Reiterated | Overweight | 2025-02-12 | $105.00 | −29.90% |
Baird | Reiterated | Neutral | 2025-02-12 | — | — |
Raymond James | Upgraded | Market Perform → Outperform | 2024-07-08 | $93.00 | −38.00% |
Benchmark | Reiterated | Buy | 2023-08-08 | — | — |
Cowen & Co. | Reiterated | Outperform | 2023-02-06 | — | — |
SVB Leerink | Reiterated | Market Perform | 2023-02-03 | — | — |
Argus Research | Upgraded | Hold → Buy | 2022-01-28 | — | — |
Bernstein | Upgraded | Market Perform → Outperform | 2021-04-01 | $160.00 | +6.80% |
Redburn | Upgraded | Neutral → Buy | 2021-03-30 | — | — |
Redburn Partners | Upgraded | Neutral → Buy | 2021-03-30 | — | — |
Credit Suisse | Reiterated | Neutral | 2021-02-05 | — | — |
SunTrust Robinson Humphrey | Upgraded | Sell → Hold | 2020-05-26 | — | — |
CFRA | Reiterated | Sell | 2020-04-29 | — | — |
DZ Bank | Upgraded | Hold → Buy | 2020-03-18 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2020-01-21 | — | — |
Guggenheim Securities | Downgraded | Buy → Neutral | 2020-01-21 | — | — |
Longbow Research | Downgraded | Buy → Neutral | 2019-04-16 | — | — |
PiperJaffray | Downgraded | Overweight → Neutral | 2018-10-26 | — | — |
Argus | Upgraded | Hold → Buy | 2018-05-05 | — | — |
Leerink Swann | Reiterated | Market Perform | 2018-02-07 | — | — |
Bank of America | Reiterated | Neutral | 2018-02-07 | — | — |
Jefferies | Upgraded | Hold → Buy | 2018-01-26 | $180.00 | +20.10% |
Summit Redstone Partners | Reiterated | Hold | 2016-12-01 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2016-11-14 | — | — |
Berenberg | Reiterated | Buy | 2016-09-22 | — | — |
Gabelli & Co. | Reiterated | Buy | 2016-06-01 | — | — |
Standpoint Research | Reiterated | Buy | 2016-02-03 | — | — |
Atlantic Equities | Reiterated | Neutral | 2015-12-18 | $62.00 | −58.60% |
Nomura | Reiterated | Buy | 2014-11-10 | — | — |
Edward Jones | Reiterated | Hold | 2014-10-31 | — | — |
FBR Capital | Reiterated | Outperform | 2014-10-13 | — | — |
Topeka | Reiterated | Buy | 2014-06-10 | — | — |
Topeka Capital | Reiterated | Buy | 2014-06-09 | — | — |
Stifel | Reiterated | Buy | 2014-02-05 | — | — |
Sterne Agee | Reiterated | Buy | 2013-06-25 | — | — |
Blaylock Robert Van | Reiterated | Buy | 2013-04-08 | — | — |
Brigantine | Downgraded | Buy → Hold | 2012-02-08 | — | — |
Institution
HSBC
Reiterated · Buy · 2026-09-10
$175.00
+16.80%
RBC Capital
Reiterated · Sector Perform · 2026-08-05
$123.00
−17.90%
Needham
Reiterated · Buy · 2026-08-05
$170.00
+13.40%
Cantor Fitzgerald
Reiterated · Overweight · 2026-08-05
$155.00
+3.40%
Barclays
Reiterated · Equal Weight · 2026-07-29
$145.00
−3.30%
Morgan Stanley
Reiterated · Overweight · 2026-07-27
$165.00
+10.10%
Leerink Partners
Downgraded · Outperform → Market Perform · 2026-07-21
$127.00
−15.30%
Truist Securities
Reiterated · Buy · 2026-07-07
—
—
Maxim Group
Upgraded · Hold → Buy · 2026-05-20
$165.00
+10.10%
Citigroup
Reiterated · Buy · 2026-04-13
—
—
Scotiabank
Reiterated · Sector Outperform · 2026-02-11
$177.00
+18.10%
Wells Fargo
Reiterated · Overweight · 2026-02-11
$165.00
+10.10%
UBS
Reiterated · Buy · 2026-01-26
$175.00
+16.80%
JP Morgan
Reiterated · Overweight · 2025-10-31
—
—
TD Cowen
Reiterated · Buy · 2025-10-23
—
—
BMO Capital
Reiterated · Outperform · 2025-08-08
$160.00
+6.80%
Mizuho
Reiterated · Outperform · 2025-05-05
—
—
Oppenheimer
Reiterated · Outperform · 2025-04-25
$165.00
+10.10%
B of A Securities
Reiterated · Buy · 2025-03-05
—
—
Deutsche Bank
Upgraded · Hold → Buy · 2025-02-18
$135.00
−9.90%
Goldman Sachs
Reiterated · Neutral · 2025-02-12
$71.00
−52.60%
Piper Sandler
Reiterated · Overweight · 2025-02-12
$105.00
−29.90%
Baird
Reiterated · Neutral · 2025-02-12
—
—
Raymond James
Upgraded · Market Perform → Outperform · 2024-07-08
$93.00
−38.00%
Benchmark
Reiterated · Buy · 2023-08-08
—
—
Cowen & Co.
Reiterated · Outperform · 2023-02-06
—
—
SVB Leerink
Reiterated · Market Perform · 2023-02-03
—
—
Argus Research
Upgraded · Hold → Buy · 2022-01-28
—
—
Bernstein
Upgraded · Market Perform → Outperform · 2021-04-01
$160.00
+6.80%
Redburn
Upgraded · Neutral → Buy · 2021-03-30
—
—
Redburn Partners
Upgraded · Neutral → Buy · 2021-03-30
—
—
Credit Suisse
Reiterated · Neutral · 2021-02-05
—
—
SunTrust Robinson Humphrey
Upgraded · Sell → Hold · 2020-05-26
—
—
CFRA
Reiterated · Sell · 2020-04-29
—
—
DZ Bank
Upgraded · Hold → Buy · 2020-03-18
—
—
Guggenheim
Downgraded · Buy → Neutral · 2020-01-21
—
—
Guggenheim Securities
Downgraded · Buy → Neutral · 2020-01-21
—
—
Longbow Research
Downgraded · Buy → Neutral · 2019-04-16
—
—
PiperJaffray
Downgraded · Overweight → Neutral · 2018-10-26
—
—
Argus
Upgraded · Hold → Buy · 2018-05-05
—
—
Leerink Swann
Reiterated · Market Perform · 2018-02-07
—
—
Bank of America
Reiterated · Neutral · 2018-02-07
—
—
Jefferies
Upgraded · Hold → Buy · 2018-01-26
$180.00
+20.10%
Summit Redstone Partners
Reiterated · Hold · 2016-12-01
—
—
Stifel Nicolaus
Reiterated · Buy · 2016-11-14
—
—
Berenberg
Reiterated · Buy · 2016-09-22
—
—
Gabelli & Co.
Reiterated · Buy · 2016-06-01
—
—
Standpoint Research
Reiterated · Buy · 2016-02-03
—
—
Atlantic Equities
Reiterated · Neutral · 2015-12-18
$62.00
−58.60%
Nomura
Reiterated · Buy · 2014-11-10
—
—
Edward Jones
Reiterated · Hold · 2014-10-31
—
—
FBR Capital
Reiterated · Outperform · 2014-10-13
—
—
Topeka
Reiterated · Buy · 2014-06-10
—
—
Topeka Capital
Reiterated · Buy · 2014-06-09
—
—
Stifel
Reiterated · Buy · 2014-02-05
—
—
Sterne Agee
Reiterated · Buy · 2013-06-25
—
—
Blaylock Robert Van
Reiterated · Buy · 2013-04-08
—
—
Brigantine
Downgraded · Buy → Hold · 2012-02-08
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space